Regenerative Medical Technology Group Inc. (RMTG) News
Track canonical SquawkNews coverage tagged to RMTG, Regenerative Medical Technology Group Inc.. This hub brings together deduplicated headlines about otc markets otcid, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 12 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
RMTG - RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
RMTG - RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
NEWS | Sep 21, 2026, 11:01 AM UTC
L
Regenerative Medical Technology Group launches ISSCA Integrative Fellowship program
Regenerative Medical Technology Group launched an ISSCA Integrative Fellowship in Point-of-Care Regenerative Medicine, positioned as an educational pathway into its early-stage ISSCA AI clinical-intelligence platform.
EQUITY | Sep 17, 2026, 11:11 AM UTC
L
RMTG - RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI (TM) Strategy
RMTG - RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI (TM) Strategy
NEWS | Sep 17, 2026, 11:02 AM UTC
L
RMTG’s Cellgenic division starts local commercial activity in Colombia
RMTG’s Cellgenic division begins local commercial activity in Colombia, subject to Colombian regulatory requirements.
EQUITY | Sep 08, 2026, 11:02 AM UTC
L
RMTG establishes local commercial presence in Brazil
RMTG, via Cellgenic, establishes a local commercial presence in Brazil.
EQUITY | Sep 03, 2026, 11:01 AM UTC
L
RMTG’s Cellgenic starts commercial activity in Peru
RMTG says its Cellgenic unit has commenced commercial activity in Peru, extending its Latin American footprint.
EQUITY | Sep 01, 2026, 11:01 AM UTC
L
RMTG Cellgenic introduces MUSE cell product line in four regions
RMTG says its Cellgenic division introduced the MUSE cell product line across four international regions.
EQUITY | Aug 27, 2026, 11:01 AM UTC
L
RMTG - RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
RMTG - RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
EQUITY | Aug 26, 2026, 11:02 AM UTC
L
RMTG - RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
RMTG - RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
EQUITY | Aug 24, 2026, 11:01 AM UTC
L
RMTG more than quadruples Q2 2026 revenue and gross profit
RMTG reports Q2 2026 revenue and gross profit more than quadruple versus Q2 2025, with operating income surpassing $560,000.
EARNINGS | Aug 20, 2026, 11:01 AM UTC
L
RMTG - RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
RMTG - RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
EQUITY | Aug 19, 2026, 11:25 PM UTC
L
RMTG expands Cellgenic Cancún lab with two ISO 7 clean rooms
RMTG expands Cellgenic’s Cancún laboratory infrastructure by adding two additional ISO 7 clean rooms, according to TradeXchange Newsdesk.
EQUITY | Aug 18, 2026, 11:00 AM UTC
L
RMTG - RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
RMTG - RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
EARNINGS | Aug 05, 2026, 11:01 AM UTC